Progesterone
What's New
Last Posted: Apr 09, 2021
- A Clinicogenetic Prognostic Classifier for Prediction of Recurrence and Survival in Asian Breast Cancer Patients.
Chen Ting-Hao et al. Frontiers in oncology 2021 11645853 - A meta-analysis of Watson for Oncology in clinical application.
Jie Zhou et al. Scientific reports 2021 11(1) 5792 - Clinicopathological correlates, oncological impact, and validation of Oncotype DX™ in a European Tertiary Referral Centre.
Davey Matthew G et al. The breast journal 2021 - Predicting of Sentinel Lymph Node Status in Breast Cancer Patients with Clinically Negative Nodes: A Validation Study.
Fanizzi Annarita et al. Cancers 2021 Jan 13(2) - Factors That Predict Biological Aggressiveness in Estrogen Receptor-Positive / Human Epidermal Growth Factor Receptor 2-Negative / Lymph Node-Negative Breast Cancer.
Arthur Lauren E et al. The Ochsner journal 2020 20(4) 381-387 - Relationships of physical and breast cancer phenotypes with three single-nucleotide polymorphisms (rs2046210, rs3757318, and rs3803662) associated with breast cancer risk in Japanese women.
Kawada Kengo et al. Breast cancer (Tokyo, Japan) 2020 Nov - Incorporating immunohistochemical markers into screening methods for BRCA1-mutated breast cancer.
Tuzimek Agnieszka et al. Polish journal of pathology : official journal of the Polish Society of Pathologists 2020 71(3) 261-269 - Variation in Breast Cancer Subtype Incidence and Distribution by Race/Ethnicity in the United States From 2010 to 2015.
Kong Xiangyi et al. JAMA network open 2020 Oct 3(10) e2020303 - Patterns of Biomarker Use in Cancer Treatment Among Medical Oncologists in the Philippines.
Catedral Lance Isidore et al. JCO global oncology 2020 Oct 61593-1608 - Genomic analysis of low-grade serous ovarian carcinoma to identify key drivers and therapeutic vulnerabilities.
Cheasley Dane et al. The Journal of pathology 2020 Sep
More
About PGx PHGKB
PGx PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other materials that address the translation of genomic and other precision health discoveries into improved health care and prevention related to medications....more
Content Summary
- NIH Information (1)
- COVID-19 (3)
- Human Genome Epidemiologic Studies (616)
- GWAS Studies (5)
- Human Genomics Translation/Implementation Studies (77)
- Genomic Tests Evidence Synthesis (6)
- Genomic Tests Guidelines (9)
- Tier-Classified Guidelines (3)
- Non-Genomics Precision Health (4)
- State Public Health Genomics Programs (1)
- Reviews/Commentaries (17)
- Ethical/Legal and Social Issues (ELSI) (1)
Common PGx Related Topics
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Oct 1, 2020
- Page last updated:Apr 26, 2021
- Content source: